Capital Performance Advisors’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-17
Closed -$772 1413
2024
Q3
$772 Buy
+17
New +$772 ﹤0.01% 2042